| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,899 |
3,400 |
$297K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,776 |
3,275 |
$179K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,822 |
1,414 |
$138K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,603 |
1,381 |
$119K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,034 |
929 |
$84K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,235 |
1,021 |
$84K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
533 |
491 |
$76K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,347 |
1,106 |
$38K |
| 96127 |
|
1,436 |
1,303 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
884 |
813 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
480 |
407 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
500 |
297 |
$12K |
| 90686 |
|
1,028 |
886 |
$10K |
| 90670 |
|
771 |
610 |
$10K |
| 83655 |
|
856 |
697 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
217 |
201 |
$9K |
| 90677 |
|
121 |
110 |
$8K |
| 90651 |
|
200 |
163 |
$6K |
| 90698 |
|
451 |
382 |
$5K |
| 90734 |
|
210 |
170 |
$5K |
| 0071A |
|
102 |
67 |
$4K |
| 36416 |
|
964 |
811 |
$4K |
| 90619 |
|
182 |
149 |
$4K |
| 90716 |
|
227 |
177 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
298 |
274 |
$4K |
| 90715 |
|
228 |
174 |
$3K |
| 0072A |
|
66 |
54 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
176 |
147 |
$3K |
| 90707 |
|
199 |
154 |
$3K |
| 85018 |
|
914 |
752 |
$2K |
| 90680 |
|
151 |
128 |
$2K |
| 90656 |
|
94 |
94 |
$2K |
| 90633 |
|
100 |
77 |
$1K |
| 90744 |
|
70 |
65 |
$1K |
| 90685 |
|
95 |
74 |
$666.42 |
| 96160 |
|
26 |
26 |
$379.60 |
| 94760 |
|
101 |
91 |
$352.00 |
| 99000 |
|
13 |
13 |
$304.98 |
| 90696 |
|
26 |
26 |
$300.43 |
| 87807 |
|
13 |
12 |
$130.78 |
| 99072 |
|
398 |
340 |
$83.50 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,447 |
1,196 |
$66.15 |
| 1003F |
|
851 |
643 |
$0.00 |
| 90461 |
|
477 |
399 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
120 |
114 |
$0.00 |
| 1036F |
|
84 |
82 |
$0.00 |